Table 3.

Rigor of development: standardized average scores in AGREE II domain for selected CPGs.

Title ID	Systematic methods used	Selecting criteria presented	Formulating the recommendations described	Benefits, side effects, and risks considered	Explicit link between the recommendations and evidence	Reviewed by external experts	Updating procedure provided
PRMA 2005[16]	67	78	100	100	50	17	0
ACP 2008[17]	83	100	83	67	61	0	33
SACOC 2010[18]	78	100	83	67	72	33	22
CATCM 2011[19]	72	78	100	78	50	39	89
CACMS 2012[20]	50	33	83	83	28	67	17
SMS 2013[21]	83	72	94	0	17	33	11
FSR 2014[22]	61	61	83	100	50	39	67
SOS 2015[23]	67	56	83	67	50	50	50
AACE 2016[24]	89	67	100	67	83	44	33
ACR 2017[25]	67	44	50	44	78	39	17
ISOT 2017[26]	61	78	83	67	83	39	0
CATCM 2017[27]	50	67	44	50	50	83	6
CSGGM 2018[28]	61	50	83	67	67	22	0
KSBMR 2018[29]	83	67	100	67	83	28	100
KSBMR 2019[30]	0	17	0	0	61	17	0